- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02614625
Spectral-domain Optical Coherence Tomography of the Eye
November 22, 2015 updated by: Augenabteilung Allgemeines Krankenhaus Linz
A Prospective, Comparative, Observational Study on Spectral-domain Optical Coherence Tomography of the Eye
An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new clinical applications has recently been published in the peer-reviewed literature.
However, the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity, biometric accuracy and reliability of the SD-OCT machines.
This prospective, comparative, observational study aims to evaluate the imaging quality and diagnostic performance of two commercially available SD-OCT machines for both the anterior and posterior segment of the eye.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oberösterreich
-
Linz, Oberösterreich, Austria, 4021
- Recruiting
- AKH Linz
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
200 eyes of 100 patients will be included.
Description
Inclusion Criteria:
- Age 21 and older
- Normal eyes or
- Eyes with corneal disease:
Subjects that have any of the following conditions
- Corneal dystrophy or degeneration
- Corneal scarring
- Corneal ulcer
- Corneal injury
- Keratoconus
- Patients who had undergone corneal surgery
- Patients with other corneal disease or - Eyes with retinal disease:
Subjects that have any of the following conditions:
- Diabetic macular edema
- Cystoid macular edema
- Age related macular degeneration
- Retinal vascular disorders (e.g. retinal artery occlusion)
- Epiretinal membrane
- Choroidal nevus
- Macular hole
- Patients who had undergone retinal surgery
Patients with other retinal disease or
- Eyes with glaucoma
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant.
AND
- Written informed consent prior to recruitment
Exclusion Criteria:
Any of the following will exclude a subject from the study:
- Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus)
- Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment into the trial)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Normal subjects
Patient with healthy, normal eyes
|
|
Eyes with corneal disease
Subjects that have any of the following conditions
|
|
Eyes with retinal disease
Subjects that have any of the following conditions:
|
|
Eyes with glaucoma
Eyes diagnosed with glaucoma of any type and any stage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity as the proportion of anatomical structures that are detectable with the two instruments
Time Frame: 6 months
|
Anatomical structures include e.g.
sublayers of the cornea, sublayers of the retina, retinal vessels etc.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Corneal sublayer thickness (µm) and retinal sublayer thickness (µm) obtained with the two study instruments
Time Frame: 6 months
|
Comparability is analyzed between various biometric values obtained with the two instruments and typical indices of comparability are produced (e.g.
intraclass correlation coefficient)
|
6 months
|
|
Corneal sublayer thickness and retinal sublayer thickness obtained with the two study instruments
Time Frame: 6 months
|
Repeatability for various biometric values obtained with the two instruments is analyzed and typical indices of repeatability are produced (e.g.
coefficient of variation)
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Matthias Bolz, MD, AKh Linz, Augenabteilung
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
October 12, 2015
First Submitted That Met QC Criteria
November 22, 2015
First Posted (Estimate)
November 25, 2015
Study Record Updates
Last Update Posted (Estimate)
November 25, 2015
Last Update Submitted That Met QC Criteria
November 22, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OCTComparisonstudy1.1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia